Funding Cancer Research at Trinity College Dublin
Trinity researchers and clinical scientists are working together with clinicians in an effort to improve the treatment and outcomes of patients with cancer both at an individual and national level and to reduce the incidence of cancer nationally and internationally. Cancer is a leading cause of death worldwide. The National Cancer Registry estimates that the incidence of cancer in Ireland will increase by 50% from 2010 to 2025 and by 100% by 2040.
In 2016 the Trinity St. James’s Cancer Institute was established with the aim of consolidating cancer activities and expertise in a dedicated facility. The Institute will transform cancer care integrating medicine and science with the goal of enhancing patient outcomes in cancer prevention, treatment and survivorship.
In June 2017 the Cancer Institute became the first Irish member of the Organisation of European Cancer Institutes (OECI), a non-governmental organisation that promotes standards in cancer centres, and is going through its accreditation. The Cancer Institute’s goals are in line with the Government’s strategy – in July 2017 the Government announced the need for at least one comprehensive centre for Ireland in its cancer strategy.
Creating a comprehensive cancer centre
The Trinity St. James’s Cancer Institute will bring focus on integrating basic and translational research, integrating care with this research, improving the broad cancer education agenda, ensuring access to best cancer practices and treatments, as well as leveraging core facilities for the benefit patients. Patients will follow personalised treatment plans developed following molecular diagnosis. Building capacity will also lead to an enlarged clinical trials participation, which is considered to be a very important factor in delivering better outcomes for patients.